Celiac Disease Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Celiac Disease Market Size Forecast: How Large Could The Market Become By 2030?
The market for celiac disease has experienced rapid expansion in recent years. Projections indicate it will rise from $0.78 billion in 2025 to $0.87 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.3%. This historical growth has been driven by heightened awareness of autoimmune conditions, advancements in diagnostic methods, the uptake of dietary management approaches, specialized gastroenterology services in hospitals, and the influence of patient advocacy efforts.
The market for celiac disease is projected to experience significant expansion over the coming years. By 2030, it is anticipated to reach a valuation of $1.27 billion, driven by a compound annual growth rate (CAGR) of 10.0%. Key factors fueling this growth during the forecast period include the development of innovative drugs, advances in gluten-free food products, tailored nutritional approaches, early detection initiatives, and investigations into the microbiome. Prominent trends shaping this period encompass a growing preference for gluten-free diets, the increasing availability of packaged gluten-free items, the emergence of pharmaceutical therapies, heightened disease recognition and diagnostic rates, and a concentrated effort on microbiome-centered interventions.
Download A Free Sample Report For Comprehensive Market Insights:
#Celiac Disease Market Growth Factors: Which Forces Are Supporting Market Expansion?
The expansion of personalized medicine is anticipated to propel the celiac disease market forward. This healthcare approach tailors medical interventions to an individual’s genetic makeup, environment, and lifestyle. Its growing adoption is fueled by wider access to genetic testing, which facilitates more precise diagnoses and customized treatments for specific patient requirements. By enabling the accurate identification of genetic markers and unique immune responses, personalized medicine enhances celiac disease management through more effective and individualized strategies. For example, the Personalized Medicine Coalition, a US-based nonprofit, reported in February 2024 that the FDA approved 16 personalized therapies for rare diseases in 2023, up from 6 in 2022. Consequently, the rise of personalized medicine will drive growth in the celiac disease market.
Celiac Disease Market Categorization By Product Type And Application
The celiac disease market covered in this report is segmented –
1) By Treatment: Larazotide Acetate, Gluten Free Diet, Other Treatments
2) By Route Of Administration: Oral, Parenteral
3) By End Users: Hospitals, Homecare, Other End-Users
Subsegments:
1) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy
2) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages
3) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators
Celiac Disease Market Industry Trends: What Changes Are Reshaping Demand?
Key players in the celiac disease market are concentrating on creating innovative therapies, including anti-interleukin-15 (IL-15) antibodies, aimed at minimizing tissue damage by curbing excessive immune cell activity. These anti-IL-15 antibodies are specialized proteins designed to block the IL-15 cytokine, thereby regulating immune responses and reducing inflammation. A notable example occurred in May 2025, when Teva Pharmaceutical Industries, headquartered in Israel, revealed that the U.S. Food and Drug Administration had awarded Fast Track designation to TEV-53408, an experimental anti-IL-15 antibody. This investigational monoclonal antibody is intended for celiac disease patients who adhere to a gluten-free diet. It works by inhibiting interleukin-15 (IL-15), a key molecule that triggers the immune response responsible for intestinal damage in individuals with celiac disease. Currently, the therapy is undergoing a Phase 2a clinical trial to assess its safety and efficacy.
Celiac Disease Market Company Landscape And Strategic Competition
Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.
Access The Complete Celiac Disease Market Report:
Celiac Disease Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the celiac disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
